Special Investigation in Patients With Crohn's Disease (All Patients Investigation)

Study Identifier
P12-706
CT.gov Identifier
NCT01298648
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Crohn's Disease (CD)
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    16 - 99 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * All patients with moderate or severe active Crohn's disease who are not responding well to conventional therapy and receive Humira will be enrolled in the survey
    Exclusion Criteria:
    Contraindications according to the Package Insert * Patients who have serious infections * Patients who have tuberculosis * Patients with a history of hypersensitivity to any ingredient of Humira * Patients who have demyelinating disease or with a history of demyelinating disease * Patients who have congestive cardiac failure

    Protocol Summary

    This study will be conducted to assess adverse drug reactions, incidence of adverse events, and factors that may affect the safety and effectiveness of Humira for the treatment of Crohn's disease.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 60378
    Abiko, Japan
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 48682
    Aichi, Japan
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 48693
    Aichi, Japan
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 49011
    Aichi, Japan
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 49013
    Aichi, Japan
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 49015
    Aichi, Japan
    Status
    Not applicable
    Showing {first} - {last} of {total} Results